Seminar Series: COVID-19 and the Law: The Use of Biotech in the COVID-19 Pandemic

Join us on February 23 for the third installment of the COVID-19 and the Law: Disruption, Impact, and Legacy Seminar Series.

This seminar series will consider the ethical, legal, regulatory, and broader social and institutional impacts that COVID-19 has had, as well as the longer-lasting effects it may have on our society. This third seminar in the series will focus on the use of biotech in the COVID-19 pandemic.

The COVID-19 pandemic has affected almost all aspects of life in the United States and around the world, disrupting the global economy as well as countless institutions. The issues raised by the COVID-19 pandemic present a critical juncture for the U.S. and other countries around the world. Our actions now have the potential to shape responses to future pandemics, and to ensure institutions serve all of our populations.

How have our institutions, including the structure of our health care system and its attendant regulations, affected the evolution of the pandemic? What lasting changes have legal responses to COVID-19 introduced? Which institutions and intersectional issues have worsened or complicated the impact of and response to the pandemic? Join us for a critical reflection on changes the pandemic has introduced and their anticipated legacy.